AMBER WHITEHILL: Open Payments
NPI 1306464375 · SPRINGFIELD, MA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$4,181 in 169 payments from 19 companies in 2025. Trend: 2023 $18 · 2024 $1,931 · 2025 $4,181
Food & beverage: $3,977Education: $204
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 35 | $1,110 |
| Regeneron Healthcare Solutions, Inc. | 18 | $619 |
| Lilly USA, LLC | 13 | $363 |
| Amgen Inc. | 22 | $323 |
| CSL Behring | 9 | $295 |
| GENZYME CORPORATION | 9 | $228 |
| Pharming Healthcare, Inc. | 11 | $204 |
| Novartis Pharmaceuticals Corporation | 16 | $197 |
| Takeda Pharmaceuticals U.S.A., Inc. | 8 | $147 |
| Genentech USA, Inc. | 5 | $116 |
Products named: DUPIXENT, TEZSPIRE, FASENRA, EBGLYSS, AIRSUPRA, Hizentra, RUCONEST, XOLAIR.
Industry payments across MA — which companies pay providers there.
